Michael Bietenbeck

661 total citations
30 papers, 379 citations indexed

About

Michael Bietenbeck is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Bietenbeck has authored 30 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Bietenbeck's work include Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Advanced MRI Techniques and Applications (8 papers) and Cardiomyopathy and Myosin Studies (7 papers). Michael Bietenbeck is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Advanced MRI Techniques and Applications (8 papers) and Cardiomyopathy and Myosin Studies (7 papers). Michael Bietenbeck collaborates with scholars based in Germany and United Kingdom. Michael Bietenbeck's co-authors include Ali Yılmaz, Udo Sechtem, Anca Florian, Claudia Meier, Cornelius Faber, Johannes Waltenberger, Sabine Rösch, Markus A. Engelen, Jörg Stypmann and Michael Möhr and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Heart Journal.

In The Last Decade

Michael Bietenbeck

26 papers receiving 377 citations

Peers

Michael Bietenbeck
Mihaela Rusu Romania
Elizabeth Juneman United States
Xueqin Xu China
Paula Camacho United States
Dong Ryeol Ryu South Korea
Elisa A. Ferrante United States
Michael Bietenbeck
Citations per year, relative to Michael Bietenbeck Michael Bietenbeck (= 1×) peers Theresa Reiter

Countries citing papers authored by Michael Bietenbeck

Since Specialization
Citations

This map shows the geographic impact of Michael Bietenbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bietenbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bietenbeck more than expected).

Fields of papers citing papers by Michael Bietenbeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Bietenbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bietenbeck. The network helps show where Michael Bietenbeck may publish in the future.

Co-authorship network of co-authors of Michael Bietenbeck

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Bietenbeck. A scholar is included among the top collaborators of Michael Bietenbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Bietenbeck. Michael Bietenbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bietenbeck, Michael, et al.. (2025). Diagnostic value of bone scintigraphy versus cardiovascular magnetic resonance in cardiac amyloidosis. Journal of Cardiovascular Magnetic Resonance. 27(1). 101859–101859.
2.
Bietenbeck, Michael, Michael Schäfers, Michael Möhr, et al.. (2024). Cardiac Sarcoidosis—Diagnostic and Therapeutic Challenges. Journal of Clinical Medicine. 13(6). 1694–1694. 4 indexed citations
3.
Meier, Claudia, et al.. (2023). A case series of double-chambered left ventricle detected by cardiovascular magnetic resonance. European Heart Journal - Case Reports. 7(5). ytad173–ytad173.
4.
Meier, Claudia, et al.. (2022). Serial Cardiovascular Magnetic Resonance Studies Prior to and After mRNA-Based COVID-19 Booster Vaccination to Assess Booster-Associated Cardiac Effects. Frontiers in Cardiovascular Medicine. 9. 877183–877183. 2 indexed citations
5.
Meier, Claudia, et al.. (2022). Cardiovascular Magnetic Resonance-Guided Radiofrequency Ablation. JACC. Clinical electrophysiology. 8(2). 261–274. 5 indexed citations
6.
7.
Bietenbeck, Michael, et al.. (2022). A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis. Scientific Reports. 12(1). 21755–21755. 5 indexed citations
8.
Bietenbeck, Michael, et al.. (2021). CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis. Scientific Reports. 11(1). 15521–15521. 25 indexed citations
9.
Bietenbeck, Michael, et al.. (2021). Diagnosis of Cardiac Involvement in Amyloid A Amyloidosis by Cardiovascular Magnetic Resonance Imaging. Frontiers in Cardiovascular Medicine. 8. 757642–757642. 5 indexed citations
10.
Evers, Georg, Claudia Meier, Michael Bietenbeck, et al.. (2020). Immune Checkpoint Inhibitor-Associated Myocarditis. SHILAP Revista de lepidopterología. 2(4). 630–635. 6 indexed citations
11.
Bietenbeck, Michael, Ahmed Elsanhoury, Carsten Tschöpe, et al.. (2020). Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study. Clinical Research in Cardiology. 110(4). 555–568. 43 indexed citations
12.
Bietenbeck, Michael, et al.. (2019). Introduction of a CMR-conditional cardiac phantom simulating cardiac anatomy and function and enabling training of interventional CMR procedures. Scientific Reports. 9(1). 19852–19852. 2 indexed citations
13.
Bietenbeck, Michael, et al.. (2019). Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1. Clinical Research in Cardiology. 108(8). 857–867. 18 indexed citations
14.
Bietenbeck, Michael, et al.. (2019). “Myocardial transit-time” (MyoTT): a novel and easy-to-perform CMR parameter to assess microvascular disease. Clinical Research in Cardiology. 109(4). 488–497. 5 indexed citations
15.
Bietenbeck, Michael, et al.. (2018). Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging. Clinical Research in Cardiology. 107(11). 1062–1070. 11 indexed citations
16.
Masthoff, Max, Sandra Gran, Xueli Zhang, et al.. (2018). Temporal window for detection of inflammatory disease using dynamic cell tracking with time-lapse MRI. Scientific Reports. 8(1). 9563–9563. 14 indexed citations
18.
Yılmaz, Ali, et al.. (2016). Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?. International Journal of Nanomedicine. Volume 11. 3191–3203. 48 indexed citations
19.
Florian, Anca, Sabine Rösch, Michael Bietenbeck, et al.. (2015). Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study. European Heart Journal - Cardiovascular Imaging. 17(3). 326–333. 55 indexed citations
20.
Bietenbeck, Michael, Anca Florian, Udo Sechtem, & Ali Yılmaz. (2015). The diagnostic value of iron oxide nanoparticles for imaging of myocardial inflammation – quo vadis?. Journal of Cardiovascular Magnetic Resonance. 17(1). 54–54. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026